Τίτλος:
Nanomedicines and Nanosimilars: Looking for a New and Dynamic Regulatory “Astrolabe” Inspired System
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
The application of the nanotechnology in medicine and pharmaceutics opens new horizons in therapeutics. Several nanomedicines are in the market and an increasing number is in clinical trials. But which is the advantage of the medicines in nanoscale? The scientists and the regulatory authorities agree that the size and consequently the physiochemical/biological properties of nanomaterials play a key role in their safety and effectiveness. Additionally, all of them agree that a new scientific-based regulatory landscape is required for the establishment of nanomedicines in the market. The aim of this review is to investigate the parameters that the scientists and the regulatory authorities should take into account in order to build up a dynamic regulatory landscape for nanomedicines. For this reason, we propose an “astrolabe-like system” as the guide for establishing the regulatory approval process. Its function is based on the different physicochemical/biological properties in comparison to low molecular weight drugs. © 2020, American Association of Pharmaceutical Scientists.
Συγγραφείς:
Demetzos, C.
Kavatzikidou, P.
Pippa, N.
Stratakis, E.
Περιοδικό:
AAPS PharmSciTech
Λέξεις-κλειδιά:
excipient; nanocarrier; nanomaterial; nanosimilar; unclassified drug; biosimilar agent, drug delivery system; human; molecular weight; nanomedicine; nanotechnology; nonhuman; physical chemistry; priority journal; Review; drug approval; drug control; legislation and jurisprudence; nanomedicine, Biosimilar Pharmaceuticals; Drug and Narcotic Control; Drug Approval; Humans; Nanomedicine
DOI:
10.1208/s12249-019-1573-y